Information Provided By:
Fly News Breaks for April 17, 2019
CAH
Apr 17, 2019 | 16:29 EDT
Guggenheim analyst Glen Santangelo initiated Cardinal Health with a Neutral rating and a price target of $51. The analyst says that while the company is "operating in a difficult environment in both its Pharmaceutical and Medical segments", it is showing signs of stabilization operationally. Santangelo also warns however that Cardinal Health's upside potential will be limited as long as investors are focused on the "potential for unfavorable regulatory change and the implications of the ongoing opioid litigation."
News For CAH From the Last 2 Days
CAH
CAH
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.